Proatherogenic mechanisms in subclinical hypothyroidism: Hepatic lipase activity in relation to the VLDL remnant IDL

Thyroid

Volumn 18, Issue 11, 2008, Pages 1233-1236

  Brenta, Gabriela ^a   Berg, Gabriela ^b   Zago, Valeria ^b   Muzzio, Maria Luz ^b   Schnitman, Marta ^a   Sinay, Isaac ^a   Arias, Pablo ^a   Schreier, Laura ^b  

^a HOSPITAL FRANCÉS   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; INTERMEDIATE DENSITY LIPOPROTEIN; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; ENZYME ACTIVITY; FEMALE; HUMAN; HYPOTHYROIDISM; LETTER; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; CHOLESTEROL; FEMALE; HUMANS; HYPOTHYROIDISM; LIPASE; LIPOPROTEINS; LIPOPROTEINS, IDL; MIDDLE AGED; YOUNG ADULT;

EID: 56549105043     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2008.0005     Document Type: Letter

References (17)

1. Zilversmit DB 1995 Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin Chem 41:153-158.
2. Masuoka H, Kamei S, Ozaki M, Kawasaki A, Shintani U, Ito M, Nakano T 2000 Predictive value of remnant-like particle cholesterol as an indicator of coronary artery stenosis in patients with normal serum triglyceride levels. Intern Med 39:540-546.
3. Ito M, Takamatsu J, Matsuo T, Kameoka K, Kubota S, Fukata S, Tamai H, Miyauchi A, Kuma K, Hanafusa T 2003 Serum concentrations of remnant-like particles in hypothyroid patients before and after thyroxine replacement. Clin Endocrinol (Oxf ) 58:621-626.
4. Ito M, Takamatsu J, Sasaki I, Hiraiwa T, Fukao A, Murakami Y, Isotani H, Miyauchi A, Kuma K, Hanafusa T 2004 Disturbed metabolism of remnant lipoproteins in patients with subclinical hypothyroidism. Am J Med 117:696-699.
5. Brenta G, Berg G, Arias P, Zago V, Schnitman M, Muzzio ML, Sinay I, Schreier L 2007 Lipoprotein alterations, hepatic lipase activity, and insulin sensitivity in subclinical hypothyroidism: response to L-t(4) treatment. Thyroid 17:453-460.
6. Landin B, Nilsson A, Twu JS, Schotz MC 1984 A role for hepatic lipase in chylomicron and high density lipoprotein phospholipid metabolism. J Lipid Res 25:559-563.
7. Wieland H, Seidel D 1973 Improved techniques for assessment of plasma lipoprotein patterns. II. Rapid method for diagnosis of type III hyperlipoproteinemia without ultracentrifugation. Clin Chem 19:1139-1141.
8. Wikinski RLW, Schreier LE, Rosental SB 1991 New method for isolating and quantifying intermediate and beta-very-low-density lipoprotein cholesterol. Clin Chem 37:1913-1916.
9. Demant T, Carlson LA, Holmquist L, Karpe F, Nilsson-Ehle P, Packard CJ, Shepherd J 1988 Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein. J Lipid Res 29:1603-1611.
10. Packard CJ, Shepherd J, Lindsay GM, Gaw A, Taskinen MR 1993 Thyroid replacement therapy and its influence on post-heparin plasma lipases and apolipoprotein-B metabolism in hypothyroidism. J Clin Endocrinol Metab 76:1209-1216.
11. Phillips NR, Waters D, Havel RJ 1993 Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 88:2762-2770.
12. Kugiyama K, Doi H, Takazoe K, Kawano H, Soejima H, Mizuno Y, Tsunoda R, Sakamoto T, Nakano T, Nakajima K, Ogawa H, Sugiyama S, Yoshimura M, Yasue H 1999 Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation 99:2858-2860.
13. Nakada Y, Kurosawa H, Tohyama J, Inoue Y, Ikewaki K 2007 Increased remnant lipoprotein in patients with coronary artery disease - evaluation utilizing a newly developed remnant assay, remnant lipoproteins cholesterol homogenous assay (RemL-C). J Atheroscler Thromb 14:56-64.
14. Kawakami A, Tanaka A, Chiba T, Nakajima K, Shimokado K, Yoshida M 2003 Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation. Circulation 108:2679-2688.
15. Cappola A, Ladenson P 2003 Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 88:2438-2444.
16. Biondi B, Klein I 2004 Hypothyroidism as a risk factor for cardiovascular disease. Endocrine 24:1-13.
17. Duntas LH, Wartofsky L 2007 Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence? Thyroid 17:1075-1084.